Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People with Type 2 Diabetes: A Case Series and Expert Opinion
Roles
Author
Document Type
Article
Publication Date
1-1-2024
Recommended Citation
Ehrhardt, N., Aroda, V., Galindo, R., Peters, A., & Shubrook, J. H. (2024). Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People with Type 2 Diabetes: A Case Series and Expert Opinion. Clinical Diabetes, 42 (2), 341–350. https://doi.org/10.2337/cd23-0047
